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When antibodies against a  well-defined antigen are used to immunize animals of 
the same genetic background, the antibodies raised are referred to as antiidiotypic (1- 
8).  It has recently been recognized  that  four types of antiidiotypic  antibodies  may 
actually be induced  (5, 6). The first type is directed against idiotopes associated with 
the combining site of the immunizing antibodies and is generally hapten inhibitable. 
The second type is composed of antibodies directed against idiotopes associated with 
the framework of the V  region. A third kind of antibodies may interact with epitope- 
or  idiotope-related  structures  of antibodies.  The  fourth  type of Ig that  may result 
from  the  injection  of  antibodies  apparently  mimics  the  original  antigen.  These 
antibodies  are said to constitute  the  "internal  image" of the initial  immunogen  (7) 
and have been termed "homobodies" by Lindenmann  (8). 
Most studies concerning idiotype recognition have involved systems in which  the 
primary antigens  are  molecules devoid of known  biological  function,  thus  making 
identification  of internal  image  difficult.  However,  recent  reports  have  described 
systems  in  which  allotypic  (9)  or  biological  properties  of  antigens  are  indeed 
"mimicked" by  immunological  "internal  images."  In  particular,  antibodies  raised 
against anti-hormone antibodies have been observed to bind hormone receptors and 
to trigger hormone-regulated physiological responses (10-17). 
This anti-receptor antiidiotypic response is generally transient.  In our experience, 
anti-catecholamine hormone antiidiotypic antibodies that specifically bound fl-adre- 
nergic receptors appeared soon after immunization, but were hardly detectable 6-10 
wk later (12,  13). In some instances, additional injections of anti-hormone antibodies 
caused the reappearance of anti-receptor antibodies.  Similar observations have been 
reported by Homcy et al.  (14)  for the catecholamine system and by Farid et al.  (15) 
for the  thyrotropin-sensitive adenylate  cyclase.  Wasserman  et  al.  (16)  showed  that 
experimental  myasthenia  gravis  induced  in  rabbits  by  the  injection  of antibodies 
directed against an acetylcholine antagonist was also transient,  apparently in direct 
relationship  to the  rapid clearance  from the sera of the anti-acetylcholine  receptor 
antiidiotypic antibodies. 
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This  report  analyzes  the  transient  character  of  the  anti-receptor  antiidiotypic 
response  to  antibody against  catecholamines. The  present  results  suggest  that  the 
synthesis  of anti-hormone antibodies  subsequent  to  the  immunization with  anti- 
hormone  antibody may  play  a  major  role  in  the  regulatory network  of idiotypic 
antiidiotypic interactions. 
Materials and Methods 
Animal  Immunization  and  Preparation of Antibodies.  Antiidiotypic antibodies were  raised  in 
rabbits by intradermal injection of anti-alprenolol IgG from allotype-matched rabbits. The 
isolation and  purification of IgG  was  performed  by  33%  ammonium sulfate  precipitation 
followed  by  dialysis  and  ion  exchange  chromatography  on  DEAE-cellulose as  previously 
described (12). The IgG fraction was concentrated by a further ammonium sulfate precipitation 
and stored in aliquots at -20°C. 
Affinity  Chromatography.  Anti-alprenolol IgG was  coupled  to  Sepharose  4B  by cyanogen 
bromide (CNBr) ~ activation as described by Mach et al. (18) using 4 g of Sepharose 4B  (net 
weight), 0.5 g CNBr, and 40 mg of antibody dissolved in phosphate-buffered saline (PBS). The 
resulting gel was suspended in PBS containing azide and stored at 4°C. 
The immunoabsorbent gel was packed in a column (0.5 ×  6 cm). IgG fractions were passed 
through the column and the gel was washed with PBS until no significant absorbance (<0.01) 
was  detected.  Elution was  then  performed  with  3%  acetic  acid;  the  eluted  fractions were 
immediately neutralized with Tris-HCl (1  M, pH 8.2). Effluents and eluates were extensively 
dialyzed against  PBS  at  4°C,  concentrated by  vacuum dialysis,  and stored  in aliquots at 
-20°C. 
Preparation of Turkey Erythrocyte Membranes.  Turkey blood was mixed with citrate buffer and 
diluted with  145 mM NaC1. After centrifugation, the plasma and buffy coat were removed, 
The washed cells were lysed in 5 mM Tris-HC1 (pH 7.4), 2 mM MgCI2 buffer and homogenized. 
After centrifugation, the  supernatant was  removed and the  upper pink layer of the  pellet 
(erythrocyte ghosts) was collected and suspended in 10 mM Tris-HC1 (pH 7.4), 145 mM. NaCI, 
2  mM  MgC12 (buffer A).  After washing, the  resulting ghosts  were  suspended  in buffer A 
containing glycerol  and stored in liquid nitrogen. The procedure has been described in detail 
elsewhere  (19). 
Immunofluorescence Studies.  Turkey erythrocytes (10  ~ ceils) were incubated with IgG fractions 
for 1 h at 30°C. After washing with PBS, cells were reincubated with fluorescein isothiocyanate- 
labeled goat anti-rabbit IgG for  1 h at 30°C. The cells were observed in a Leitz fluorescence 
microscope (E. Leitz). 
Binding Assays.  Binding of (-)-[aH]dihydroalprenolol (-)-[3H]DHA to each  fraction was 
assayed by means of an ammonium sulfate precipitation assay (Farr assay). Briefly, IgG samples 
were incubated overnight at 4°C with (-)-[3H]DHA, then precipitated with 50% ammonium 
sulfate, and finally filtered on glass fiber filters. Antiidiotypic IgG was detected by inhibition 
of (-)-[3H]DHA to fl-adrenergic receptor from turkey erythrocyte membranes. Turkey eryth- 
rocyte membranes were  preincubated with dilutions of IgG fractions from each bleeding or 
with dilutions of corresponding passthrough and eluted fractions from the Ab 1-Sepharose  gel 
for  1 h  at  30°C in 75  mM Tris-HC1 buffer, pH  7.4/25 mM MgCI~. Membranes were then 
tested for their ability to bind (-)-[aH]DHA after 8 min incubation at 30°C and finally filtered 
on glass-fiber filters  (12). 
Results 
Preparation  and  Characterization  of Anti-alprenolol  Antibodies.  Antibodies against  al- 
prenolol, a  potent catecholamine antagonist, were raised in a  rabbit by injection of 
alprenolol linked to  bovine serum albumin (20).  The antibodies specifically bound 
1Abbreviations used in  this paper." Abl, anti-epitope-antibody; Ab2, antiidiotype antibody;  Ab3, anti- 
antiidiotype  antibody;  CNBr, cyanogen bromide;  (-)-[3H]DHA,  dihydroalprenolol; PBS, phosphate- 
buffered saline. COURAUD, LU, AND STROSBERG  1371 
(-)-[aH]DHA with an apparent dissociation constant of 1.1 X 10  -7 M  and represented 
~1.5%  of the total IgG fraction, further designated as Abl  throughout this report. 
The Ab 1 binds other catecholamine antagonists such as propranolol and agonists such 
as  isoproterenol  (12).  The antibody-containing IgG fraction obtained  from pooled 
bleedings from a  single animal was injected into four allotypically matched rabbits: 
31, 35, 57, and 58 to induce the synthesis of antiidiotypic antibodies (Ab2). 
Transient Character of the  Antiidiotypic  Response to  Abl.  Antiidiotypic  activity was 
monitored in the serum of the immunized rabbits by following the capacity to inhibit 
the binding of catecholamine ligands to the anti-alprenolol antibodies and to the B- 
adrenergic receptors (12).  In our initial study (12), this activity was detected only in 
the  serum  of rabbit  31.  It  appeared  the  6th  wk  after  initial  immunization,  and 
disappeared  10 wk later.  It could not  be detected in  the serum  of the other three 
immunized  rabbits.  The  transient  character of the  antiidiotypic response  to  anti- 
alprenolol antibodies was also described in another study in which only 1 animal out 
of 11  appeared to respond  (14).  We were intrigued by this low responsiveness and 
decided to investigate the presence of antibodies that  might neutralize the antiidi- 
otypic antibodies. 
Alprenolol-binding Capacity in  Sera of Rabbits Immunized  with Anti-alprenolol Antibodies. 
When testing the IgG fraction from each bleeding from rabbit  31, it appeared that 
the decrease of adenylate cyclase stimulating antiidiotypic antibodies was accompa- 
nied by an increase of alprenolol-binding activity. We therefore decided to investigate 
this activity in the serum of the apparently nonresponding rabbits. In the IgG fractions 
of rabbits  57  and  58  we  detected several  periods  of production of anti-alprenolol 
antibodies  (Fig.  1). To differentiate this Abl-like activity from that  due to residual 
Abl  injected during the preceding weeks, we determined the ligand-binding affinity 
of the "new" antibodies: except for the first peak, in both rabbits it appeared to be 
higher than that of the immunogen, and decreased progressively from one peak to the 
next  (Fig.  2).  Because we suspected  that  the  Abl-like  response was  due  in  fact to 
antiidiotypic antibodies against Ab2 molecules themselves raised against the injected 
Ab 1, we prepared an Ab 1-agarose affinity gel to isolate the various antibody activities. 
Isolation and Characterization of Ab2 and Abl-like Antibodies.  Ig  fractions from each 
bleeding from rabbits 57 and 58 were absorbed on the Ab 1 agarose column and both 
the effluent ("pass-through") and the eluate were analyzed for the capacity to bind 
(-)-[aH]DHA (Ab l-like activity) (Fig. 1) or to inhibit this binding to the fl-adrenergic 
receptor or to anti-alprenolol antibodies (Ab2 activity). 
Alternate peaks of both types of activities could be observed (Fig. 3 B) in either the 
effluent or the eluate. Ab2 antibodies, not detected in the serum appeared to be able 
to inhibit almost all the binding of (-)-[aH]DHA to the receptor in a dose-dependent, 
saturable manner (Fig. 4). The small amount of Ab2 activity detected in the effluent 
(Fig. 3 A) might be due to saturation of the Abl  column or to competition with the 
unretained Ab l-like antibodies. 
The presence of antiidiotypic Ab2 antibodies able to interact with the alprenolol 
binding fl-adrenergic receptor  (12)  was  confirmed by immunofluorescence experi- 
ments in which turkey erythrocyte membranes known to possess fl-adrenergic receptors 
were incubated with the various fractions obtained during affinity chromatography 
on the Ab 1 agarose gel. When FITC-labeled goat anti-rabbit antibodies were added, 
only the  fractions that  inhibited  the  binding  of (-)-[aH]DHA to the fl-adrenergic 1372  CYCLIC ANTIIDIOTYPE RESPONSE  TO ANTI-HORMONE ANTIBODIES 
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Fro.  1.  (-)-[SH]DHA Binding capacity of the first bleedings of rabbit  58 (upper) and rabbit  57 
(lower) to (-)-[aH]DHA  using unfractionated IgG (El), effluents (O), and eluates (0) fractionated 
on an anti-alprenolol antibody-Sepharose column. 100/d of IgG (1 mg/ml in PBS) were incubated 
with 50/~1 of (-)-[aH]DHA. Bound radioactivity was measured by means of an ammonium sulfate 
precipitation assay (Farr assay). Nonspecific binding was determined in the presence of 1,000-fold 
propranolol and did not exceed 10% of the specific binding. Means of two experiments are shown. 
Arrows indicate times of injection of alprenolol antibodies (Abl). 
receptor stained the receptor containing membranes. 
As  for  the  direct  (-)-[SH]DHA-binding  capacity,  superimposable  results  were 
obtained  either  with  entire  IgG serum  fractions or with  the effluent  from the Abl- 
agarose gel (Fig.  1).  The comparison of the Ab2 and Abl-like  (or Ab3)  time courses 
revealed that the peaks of these two kinds of activities appeared exactly in ahernance 
all along the 5-mo-long study, independent of the booster injections  (Fig. 3 B). 
Interactions of the Ab2 with Both  Abl and Ab3.  The cyclical appearance  of the Ab2 
and Abl-like Ab3 antibodies could be explained  by reciprocal expansion of idiotypic 
and antiidiotypic clones (21) and neutralization of antibody activity by antiantibodies. 
To  verify  this  hypothesis,  the  Ab2  fractions  were  preincubated  with  increasing 
concentrations  of Abl  or Ab3, then  incubated with  membranes and tested  for their 
ability to inhibit the binding of (-)-[3H]DHA to the fl-adrenergic receptor. Both Ab 1 
and Ab3 prevented  the interaction  of Ab2 with the fl-adrenergic receptor.  A  typical 
result is shown in Fig. 5 for bleeding 58-4. 
From this experiment, it appeared that Ab3, for example from bleeding 58-5, which 
was  seen  to  exhibit  a  higher  affinity  for  (-)-[~H]DHA  than  Abl  (Fig.  3B)  also 
demonstrated  a  higher  affinity  for  Ab2  than  did  Abl  (Fig.  5).  Under  the  same 
conditions,  the  effluent  of bleeding  58-4,  which  was  negative  in  the  (-)-[SH]DHA 
binding  test  when  incubated  with  Ab2  (eluate  from  the  same  bleeding),  failed  to COURAUD, LU,  AND  STROSBERG 
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Fto.  2.  (A) Evolution of the affinity of Abl-like (-)-[~H]DHA binding capacity.  Effluents  from 
bleedings of rabbit 3 t corresponding to the peaks of (-)-[SH]DHA binding  capacity were incubated 
overnight at 4°C with increasing concentrations of (-)-[SH]DHA; nonspecific binding was deter- 
mined in the presence of a 200-fold excess of (d,1)-alprenolol. For each effluent, specific binding  was 
plotted as percent of maximum binding. (O), Abl; (Q), Ab3-peak 1; ~l), Ab3-peak 2; ([~), Ab3- 
peak 3. (B) Evolution of the affinity of Abl-like (-)-[aH]DHA binding  capacity for rabbit 58, using 
the experimental conditions described for A. (0), Abl; (A), IgG from bleeding 58-1; (D), Ab3 from 
bleeding 58-5; (m), Ab3 from bleeding 58-8; ([]), Ab3 from bleeding 58-I 1. 
inhibit  Ab2.  These  results  were  in  agreement  with  our  interpretation  that  anti- 
alprenolol  antibodies,  appearing  in  the  course  of the  Ab2  immune  response,  were 
antiidiotypic with respect to Ab2. Moreover, the binding affinity of Ab2 for Ab 1 and 
for  Ab3  were  well  conserved  during  the  course  of the  immune  response  (Fig.  5), 1374  CYCLIC  ANTIIDIOTYPE  RESPONSE  TO  ANTI-HORMONE  ANTIBODIES 
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FIG.  3.  (A) Inhibition of binding of (-)-[3H]DHA to fl-adrenergic receptor of turkey  erythrocyte 
membranes by eluates and effluents  separated on the anti-alprenolol antibody-Sepharose column. 
Turkey erythrocyte membranes were incubated with eluates (Q) and effluents  (C)) in 75 mM Tris- 
HC1 buffer, pH 7.4/2.5  mM MgClz at 30°C for 1 h, then tested for their ability to bind (-)-[3HI- 
DHA after an 8-min incubation at 30°C and filtration on glass fiber filters. Controls were made up 
with preimmune IgG. Means of two independent experiments are shown. Upper: rabbit 58; lower: 
rabbit 57. (B) A comparison of the inhibition of binding of (-)-[~H]DHA to fl-adrenergic receptor 
by eluates (Q) with the binding capacity of effluents  (C)) to (-)-[3H]DHA. Upper: rabbit 58; lower: 
rabbit 57. 
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FIG,. 4.  Inhibition of binding of (-)-[aH]DHA to fl-adrenergic receptor by increasing concentra- 
tions of Ab2 separated from bleeding 6 of rabbit 57. 
whereas as noted above, the affinities of Ab3 for (-)-[aH]DHA  or Ab2 decreased from 
one peak to the other. 
Discussion 
Jerne's network of idiotypic and antiidiotypic interactions between lymphocytes or 
their  products  postulates  the  existence  of a  dynamic  equilibrium  in  the  immune COURAUD,  LU,  AND  STROSBERG  1375 
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FIc.  5.  Inhibition of interaction  of Ab2 to fl-adrenergic  receptor by Ab I  (open symbols)  and Ab3 
(effluent  from bleeding 58-5, closed symbols).  45 #1 of Ab2  (1,000/.Lg/ml)  isolated from each of the 
successive Ab2 peaks (C) and O, eluate from 58-4; [] and ,,  eluate from 58-7;  A  and A, eluate from 
58-9)  (Fig.  3) were preincubated  with increasing concentrations of Ab 1, Ab3, or normal rabbit IgG 
as control  (0)  overnight  at 4°C,  then  incubated  with  15 #1 of membranes  (1  mg/ml)  1 h  at 30°C, 
before (-)-[aH]DHA  binding capacity of the membranes was tested in an 8-rain incubation at 30°C. 
system (7). A  foreign antigen would temporarily disturb this state by stimulating the 
production of Ab 1 antibodies. Subsequent stimulation of Ab2 antiidiotypic antibodies 
would restore the initial  steady state.  The oscillatory behavior of the system should 
not,  however,  remain  limited  to  the  Abl  and  Ab2  components;  increased  Ab2 
synthesis should stimulate Ab3 production and so on. 
Several  (10-17)  studies  have  documented  the  ability  of antiidiotypic  antibodies 
raised against anti-hormone antibodies to bind the corresponding hormone receptors. 
A  detailed analysis of the response to anti-catecholamine antibodies reveals that only 
a minority of the Ab2 molecules functions as the immunological internal image of the 
adrenergic hormones. Ab2 does not mimic all the properties of the smaller and specific 
ligands:  thus  the  syngeneic  action  between  guanyl  trinucleotides  seen  with  the 
hormone is not observed for the antibodies  (13). The Ab2 may stimulate both basal- 
and  hormone-sensitive cyclase,  suggesting  that  the  site  of action  is  not  exactly  the 
same,  an  expected  conclusion considering  the  large difference  in  size.  Not  all  anti- 
receptor Ab2  molecules have similar properties within the heterogeneous population 
of antibodies.  Some  may  act  as  agonists,  others  may  behave  as  antagonists.  The 
analysis  of the  unfractionated  population  yields  a  summation  of all  effects  which 
appears  as  agonistic  in  the  animals  we  have  studied.  In  contrast,  in  the  study  of 
Homcy  et  al.  (14)  Ab2  antibodies  raised  against  affinity-purified  anti-alprenolol 
antibodies were predominantly antagonistic. 
A  time course study  of the Ab2  response reveals a  cyclic appearance  of the anti- 
idiotypic molecules. Their disappearance could be explained by metabolism. However, 
such a process is usually slow compared with the rapid decrease in Ab2 concentration 
seen  in our study.  We  favor an active  removal mechanism  likely to result  from the 1376  CYCLIC  ANTIIDIOTYPE RESPONSE TO ANTI-HORMONE ANTIBODIES 
synthesis of a  third kind of antibody  (Ab3)  auto-antiidiotypic against Ab2  (21).  We 
isolated Ab3  by affinity chromatography on an antigen-containing  affinity column 
and were able to compare its precise binding characteristics  with  those of the Abl 
antibodies. Some of the Ab3 molecules thus mimicked the Abl original antibodies by 
binding the catecholamine ligand.  It remained to be shown that  the Ab3 molecules 
were not actually Abl, since both bind the ligands and both inhibit the action of Ab2 
in  binding  to  the  receptor.  However,  in  each  of  these  experiments,  the  binding 
properties of Ab 1 and Ab3 were shown to be different. 
The results presented here and those described by others  (14)  on the fl-adrenergic 
system,  as  well  as  the  results  of Shechter  et  al.  (22)  on  the  insulin  system, clearly 
indicate that the auto-antiidiotypic response induced by the injection of anti-hormone 
antibodies  may actually intervene in  physiological processes, as had been suggested 
earlier by Sege and Peterson (11). The synthesis by rabbits ofantiidiotypic antibodies 
that act as anti-receptor antibodies may constitute a  potent trigger for the synthesis 
ofautologous anti-antiidiotypic antibodies that could neutralize potentially detrimen- 
tal  effects of the  hormone  like  immunological  internal  images.  A  recent  study  by 
Wasserman et al.  (16)  has shown that this neutralization  event actually reverses the 
pathological developments of experimental autoimmune myasthenia gravis induced 
in rabbits immunized with antibodies against an acetylcholine analog. 
In the present study of rabbits immunized with anti-alprenolol antibody Ab 1, we 
have shown  a  cyclic appearance of antiidiotypic  antibodies  (Ab2), alternating with 
the appearance of alprenolol-binding antibodies. Anti-receptor Ab2 response, which 
is only a  fraction of the overall antiidiotypic  response to the  injection  of Abl,  has 
been documented  in  several hormonal  systems (10-17),  wherein  most authors  have 
noticed the transient aspect of this response. 
Our results confirm that  the rapid and cyclic disappearance of anti-receptor Ab2 
antibodies is due to a regulation assumed by antiidiotypic antibodies directed against 
Ab2. This reciprocal expansion ofantiidiotypic clones is supported byJerne's idiotypic 
network theory (7)  and is in agreement with other recent results  (21,  23).  Moreover, 
we have shown that at least a  fraction of these anti-antiidiotypic antibodies are able 
to bind the original antigen, i.e.,  alprenolol, and thus may be considered as Ab l-like 
antibodies.  It is interesting  to underline  the general decrease in  the affinity of these 
antibodies towards the antigen all along the immune response. This result suggests a 
degeneracy in the idiotypic response, as if the image would fit less and less its model. 
The anti-antiidiotypic antibodies are heterogeneous; some may be directed against 
the idiotype of Ab2 involved in this interaction with the hormone receptor. These are 
the Ab l-like antibodies. Others may be directed against different idiotypes of the Ab2 
molecule  and  have  no  alprenolol-binding  capacity.  One  hypothesis  could  be  that 
these anti-antiidiotypic  antibodies  are responsible  for neutralizing  the anti-receptor 
Ab2 antibodies, thus masking the Ab2 activity in the serum of immunized animals in 
varying proportions according to the animal. Fractionation of the serum on an Abl- 
containing  affinity column  separates  the  anti-antiidiotypic  antibodies  from the  re- 
tained Ab2 molecules and permits detection of the different binding activities of these 
complementary Ig. 
Summary 
Antiidiotype antibodies were raised against anti-catecholamine ligand antibodies. 
The  antiidiotype  response  was  shown  to  be  cyclical  and  to  correspond  to  the COURAUD,  LU, AND STROSBERG  1377 
production of antibodies that could bind to catecholamine fl-adrenergic receptors and 
stimulate adenylate cyclase. Disappearance of these antibodies from the serum could 
be correlated with the appearance of a  catecholamine ligand-binding activity corre- 
sponding to the synthesis of autologous anti-antiidiotype antibodies directed against 
the induced antiidiotypic molecules. Comparison of the injected versus the induced 
anti-ligand antibodies reveals striking differences in  affinities but  similarities in the 
ability to  bind  to the  antiidiotype antibodies and  to  the  ligand-containing affinity 
gel. The results support the existence of a  functional network of idiotype antiidiotype 
interactions involving external as well as internal antigens, antibodies, and possibly 
other  types  of  molecules  involved  in  recognition  phenomena,  such  as  hormone 
receptors. 
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